Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- custom synthesis
- Reagent
Supplier Region
- Maharashtra(39)
- Gujarat(26)
- Ahmedabad(1)
- Hyderabad(13)
- NaviMumbai(1)
- Bangalore(2)
- Kerela(1)
- Karnataka(8)
- Andhra Pradesh(1)
- Telangana(31)
- Uttar Pradesh(2)
- Rajasthan(2)
- New Delhi(3)
- Mumbai(6)
- Punjab(2)
- Tamil Nadu(2)
- AndhraPradesh(1)
- Madhya Pradesh(1)
Purity
- IP/USP/BP/EP
- IP/BP-EP/USP
- IP/BP/EP/USP
- IP/BP/EP
- Complies as per Monograph
- BP/EP/USP
- above 90 %
- 99%
- 98+
- 98%
- >98%
- 96%
- 95%
- 90 % Above
- 0.98
Package
- 100500100mg or 500 mg
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- 5g
- 255025 to 50 kg
- 10g
- 25g
- 50g
- 2.55022e+01025/50/220 KGS HDPE DRUM / 1060 KGS IBC TANKS
- 0Customized pack size availaible
- 100g
- 25125kg and 1 MT
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 1000kg
- 1MT
- 10mt
- 25kgs
- 50kgs
- 1001100mg and 1 g
- 50010500 mg and 1.0 gm
- 20KG
- 100kg
- 200KGS HDPE DRUM
-
ethyl 5-(forMylaMino)-1H-pyrazole-4-carboxylate
31055-19-3
-
5-METHOXY-2-[((4-METHOXY-3,5-DIMETHYL-1-OXIDO-2-PYRIDINYL)METHYL)SULFINYL]-BENZIMIDAZOLE
176219-04-8
-
Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
70844-48-3
-
3S, 5S enantioMer of Atorvastatin CalciuM
1105067-88-6
-
2-Mercaptobenzimidazole
583-39-1
-
Allopurinol
315-30-0
-
2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole
117977-21-6
-
2-Methyltetrahydropyran
10141-72-7
-
3,5-Diiodo-L-thyronine
1041-01-6
-
9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione
981-34-0
Methotrexete Related Compound E 70844-48-3
100mg and 1 g 50mg 25mg
Atorvastatin Related compound E 1105067-88-6
Allopurinol 315-30-0 / 916980-04-6
Allopurinol 315-30-0 / 916980-04-6
Allopurinol 315-30-0 / 916980-04-6
